Rossana Gueli
Ospedale di Circolo e Fondazione Macchi(IT)ATS Sardegna (Italy)(IT)
Publications by Year
Research Areas
Melanoma and MAPK Pathways, Breast Cancer Treatment Studies, Advanced Breast Cancer Therapies, Cancer Immunotherapy and Biomarkers, Computational Drug Discovery Methods
Most-Cited Works
- → Neuroendocrine breast cancer: retrospective analysis of 96 patients and review of literature(2013)49 cited
- → Psoriatic Arthritis Induced by Anti-PD1 and Treated with Apremilast: A Case Report and Review of the Literature(2020)17 cited
- → Eribulin in Male Patients With Breast Cancer: The First Report of Clinical Outcomes(2016)15 cited
- → Pyrosequencing for EGFR Mutation Detection(2013)10 cited
- → A Retrospective Analysis of Dabrafenib and/or Dabrafenib Plus Trametinib Combination in Patients with Metastatic Melanoma to Characterize Patients with Long-Term Benefit in the Individual Patient Program (DESCRIBE III)(2021)9 cited
- → Retrospective Chart Review of Dabrafenib Plus Trametinib in Patients with Metastatic BRAF V600-Mutant Melanoma Treated in the Individual Patient Program (DESCRIBE Italy)(2021)7 cited
- → Neoadjuvant Chemotherapy in Breast Cancer: Evaluation of the Impact on Surgical Outcomes and Prognosis(2024)6 cited
- → Cyclin-dependent kinase inhibitors plus aromatase inhibitor in first-line treatment hormone-receptor–positive/HER2-negative advanced breast cancer women with or without visceral disease: time to turn page?(2020)4 cited
- → Fulvestrant and trastuzumab in patients with luminal HER2-positive advanced breast cancer (ABC): an Italian real-world experience (HERMIONE 9)(2021)4 cited
- → Dabrafenib and trametinib induced pancreatitis: a case report and review of the literature(2020)4 cited